Atrial Fibrillation Detection Using Garmin Wearable Technology
| Status: | Recruiting |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/4/2019 |
| Start Date: | June 19, 2018 |
| End Date: | August 2019 |
| Contact: | Margana Morgan |
| Email: | mmorgan@kumc.edu |
| Phone: | 913-945-6443 |
The purpose of this study is to evaluate the feasibility of detecting atrial fibrillation
(AF) in patients with AF using a wearable wrist device/smart watch.
(AF) in patients with AF using a wearable wrist device/smart watch.
Even though AF is common and associated with increased risk of stroke, quite often it goes
undetected until late in the course of the condition. If AF can be detected with simpler
tools like a smart watch, it would enable providers to identify patients with AF much earlier
in the course of the condition (even before being seen by a physician) and hopefully be able
to prevent stroke. This study is being done to identify a technology that can likely identify
AF using a smart watch.
undetected until late in the course of the condition. If AF can be detected with simpler
tools like a smart watch, it would enable providers to identify patients with AF much earlier
in the course of the condition (even before being seen by a physician) and hopefully be able
to prevent stroke. This study is being done to identify a technology that can likely identify
AF using a smart watch.
Inclusion Criteria:
- All patients with AF scheduled to undergo electrical cardioversion at the University
of Kansas Health System
Exclusion Criteria:
- Patients with no detectable PPG
- Hemodynamically unstable patients
- Patients who cannot give informed consent
- Patients with tattoos on the wrists
We found this trial at
1
site
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials
